SEC 13F Intelligence

Cadence Bank / ABBV

Cadence Bank’s Abbvie Inc Position

Does Cadence Bank own Abbvie Inc (ABBV)? Yes — 63.3K shares worth $14M (+0.85% of its 13F portfolio) as of Q4 2025, up from 63.1K shares the prior filed quarter.

Position Value
$14M
Q4 2025
Shares
63.3K
% of Portfolio
+0.85%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $6MQ4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $9MQ3 ’20: $8MQ4 ’20: $10MQ4 ’20Q1 ’21: $10MQ2 ’21: $10MQ3 ’21: $10MQ4 ’21: $13MQ4 ’21Q1 ’22: $13MQ2 ’22: $12MQ3 ’22: $13MQ4 ’22: $16MQ4 ’22Q1 ’23: $16MQ2 ’23: $14MQ3 ’23: $15MQ4 ’23: $16MQ4 ’23Q1 ’24: $19MQ2 ’24: $17MQ3 ’24: $20MQ4 ’24: $18MQ4 ’24Q1 ’25: $21MQ2 ’25: $12MQ3 ’25: $15MQ4 ’25: $14MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202563.3K$14M+0.85%
Q3 202563.1K$15M+0.89%
Q2 202563.3K$12M+0.77%
Q1 2025102.4K$21M+1.53%
Q4 2024101.3K$18M+1.22%
Q3 2024100.1K$20M+1.36%
Q2 202499.4K$17M+1.28%
Q1 2024102.1K$19M+1.35%
Q4 2023103.0K$16M+1.30%
Q3 2023103.5K$15M+1.36%
Q2 2023104.8K$14M+1.23%
Q1 202399.1K$16M+1.45%
Q4 202298.3K$16M+1.47%
Q3 202297.3K$13M+1.35%
Q2 202280.9K$12M+1.78%
Q1 202281.9K$13M+1.65%
Q4 202193.2K$13M+1.57%
Q3 202192.2K$10M+1.39%
Q2 202191.9K$10M+1.50%
Q1 202190.8K$10M+1.49%
Q4 202091.9K$10M+1.54%
Q3 202086.3K$8M+1.49%
Q2 202087.3K$9M+1.77%
Q1 202085.2K$6M+1.64%
Q4 201981.0K$7M+1.33%
Q3 201980.7K$6M+0.58%
Q2 201946.8K$3M+0.33%
Q1 201943.4K$3M+0.35%
Q4 201842.6K$4M+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cadence Bank’s full portfolio or all institutional holders of ABBV.